AAAAAA

   
Results: 1-11 |
Results: 11
Molecular basis of allergic cross-reactivity between group 1 major allergens from birch and apple
Authors: Holm, J Baerentzen, G Gajhede, M Ipsen, H Larsen, JN Lowenstein, H Wissenbach, M Spangfort, MD
Citation: J. Holm et al., Molecular basis of allergic cross-reactivity between group 1 major allergens from birch and apple, J CHROMAT B, 756(1-2), 2001, pp. 307-313
Major venom allergen of yellow jackets, Ves v 5: Structural characterization of a pathogenesis-related protein superfamily
Authors: Henriksen, A King, TP Mirza, O Monsalve, RI Meno, K Ipsen, H Larsen, JN Gajhede, M Spangfort, MD
Citation: A. Henriksen et al., Major venom allergen of yellow jackets, Ves v 5: Structural characterization of a pathogenesis-related protein superfamily, PROTEINS, 45(4), 2001, pp. 438-448
Knowledge, human resources and social practice: The knowledge-intensive business service firm as a distributed knowledge system
Authors: Larsen, JN
Citation: Jn. Larsen, Knowledge, human resources and social practice: The knowledge-intensive business service firm as a distributed knowledge system, SERV IND J, 21(1), 2001, pp. 81-102
Using Newton's law and geophysical bounds on mass density contrast to ensure consistency between gravity and height data
Authors: Strykowski, G Larsen, JN
Citation: G. Strykowski et Jn. Larsen, Using Newton's law and geophysical bounds on mass density contrast to ensure consistency between gravity and height data, PHYS CH P A, 25(1), 2000, pp. 71-76
Manufacturing and standardizing allergen vaccines
Authors: Larsen, JN Lowenstein, H
Citation: Jn. Larsen et H. Lowenstein, Manufacturing and standardizing allergen vaccines, IMMUNOL ALL, 20(3), 2000, pp. 609
Therapeutic allergy vaccination causal treatment of pollen allergy. Part II
Authors: Wolf, H van Neerven, RJJ Larsen, JN Spangfort, MD Lowenstein, H
Citation: H. Wolf et al., Therapeutic allergy vaccination causal treatment of pollen allergy. Part II, ALLERGOLOGI, 23(4), 2000, pp. 182-189
Therapeutic allergy vaccination - causal treatment of pollen allergy. PartI: Allergen complexity and standardization
Authors: Larsen, JN Lowenstein, H van Neerven, RJJ Spangfort, MD Wolf, H
Citation: Jn. Larsen et al., Therapeutic allergy vaccination - causal treatment of pollen allergy. PartI: Allergen complexity and standardization, ALLERGOLOGI, 23(2), 2000, pp. 92-96
Dominant epitopes and allergic cross-reactivity: Complex formation betweena Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1
Authors: Mirza, O Henriksen, A Ipsen, H Larsen, JN Wissenbach, M Spangfort, MD Gajhede, M
Citation: O. Mirza et al., Dominant epitopes and allergic cross-reactivity: Complex formation betweena Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1, J IMMUNOL, 165(1), 2000, pp. 331-338
Allergen vaccines for specific diagnosis
Authors: Larsen, JN Lowenstein, H
Citation: Jn. Larsen et H. Lowenstein, Allergen vaccines for specific diagnosis, CL ALLER IM, 15, 2000, pp. 1-51
Crystallization and preliminary X-ray analysis of birch-pollen allergen Bet v 1 in complex with a murine monoclonal IgG Fab ' fragment
Authors: Spangfort, MD Mirza, O Svensson, LA Larsen, JN Gajhede, M Ipsen, H
Citation: Md. Spangfort et al., Crystallization and preliminary X-ray analysis of birch-pollen allergen Bet v 1 in complex with a murine monoclonal IgG Fab ' fragment, ACT CRYST D, 55, 1999, pp. 2035-2036
The structure of major birch pollen allergens - epitopes, reactivity and cross-reactivity
Authors: Spangfort, MD Mirza, O Holm, J Larsen, JN Ipsen, H Lowenstein, H
Citation: Md. Spangfort et al., The structure of major birch pollen allergens - epitopes, reactivity and cross-reactivity, ALLERGY, 54, 1999, pp. 23-26
Risultati: 1-11 |